Christopher Jewell

No más puestos en curso

Fortuna: 1 M $ al 30/06/2026

45 años

Consumer Services

Commercial Services

Perfil

Christopher Jewell worked as a Professor at the University of Maryland from 2020 to 2024.
Dr. Jewell served as Chief Scientific Officer at Cartesian Therapeutics, Inc. (United States) in 2023 and continued in the same role at Cartesian Therapeutics, Inc. from 2023 to 2025.
Dr. Jewell earned a doctorate from the University of Wisconsin.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
0,36 %	14/04/2026	104.877 ( 0,36 % )	1 M $	30/06/2026

Antiguos cargos conocidos de Christopher Jewell.

Empresas	Cargo	Fin
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/04/2024
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Director Técnico/Científico/I+D	13/11/2023

Ver el detalle de la experiencia de Christopher Jewell.

Formación de Christopher Jewell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Jewell.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Commercial Services